8th Commercializing Continuous Processing in Pharma Summit (CCP)
March 26 to March 28, 2024
Hilton Boston Back Bay, 40 Dalton Street, Boston, Massachusetts, 02115, United States
The 8th CCP Summit, a pinnacle event in the industry, converges on advancing continuous processing adoption across pharmaceuticals. From March 26th to 28th, this summit, crafted alongside industry titans, delivers cutting-edge insights from pharma and biotech leaders. With a focus on small molecules, biologics, and the latest addition of ATMPs, it harmonizes technical case studies with business realities. Attendees gain a comprehensive understanding of the transformative power of continuous processing, fortified by evolving regulatory support. With 140+ key stakeholders sharing their manufacturing odysseys, the summit ignites inspiration to hurdle obstacles, hastening drug quality and market arrival through end-to-end continuous manufacturing.
[Read on continuous-processing-pharma.com](https://continuous-processing-pharma.com/)
The 5th Glioblastoma Drug Development Summit brings together large pharma, biotech, neuro-oncologists, academic experts, and investors with a shared mission to overcome barriers in glioblastoma (GBM) treatment. The summit explores innovative strategies for crossing the blood-brain barrier, optimizing clinical trial designs, and navigating regulatory pathways for combination therapies. With advances in therapeutic modalities and emerging drug targets, the potential for GBM treatment is greater than ever. This collaborative event, featuring industry leaders, pioneering biotechs, academics, and investors, aims to elevate standards, achieve positive clinical outcomes, and unite the community in the fight against GBM and CNS tumors. The summit takes place from March 26 to 28, 2024.
The assurance cookie is found and is being filtered in Google Analytics.
These cookies are used to collect information about how you interact
with our website and allow us to remember you. We use this
information in order to improve and customize your browsing
experience, and for analytics and metrics about our visitors both on
this website and other media. To find out more about the cookies we
use, see our